pankajmathur/National_Library_of_Medicine_Studies_data huggingface dataset:
Clinical trial: Use of Low-level Laser Therapy in the Treatment of Incontinence-associated Dermatitis in the Elderly
Status: COMPLETED
Conditions: Dermatitis
Interventions: OTHER: Gentle intimate hygiene and skin protective barrier application - Persistent erythema with intact epidermis|OTHER: Gentle intimate hygiene and skin protective barrier application - Erythema with signs of epidermis loss|OTHER: Low Level Laser Therapy - Persistent erythema with intact epidermis|OTHER: Low Level Laser Therapy - Erythema with signs of epidermis loss
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for HER2 Positive Early Breast Cancer Patients
Status: RECRUITING
Conditions: HER2-positive Early Breast Cancer
Interventions: DRUG: neoadjuvant chemotherapy upon in vitro PTC drug sensitivity screenning
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Trial in Low Grade Glioma Patients: Wait or Treat
Status: TERMINATED
Conditions: Low-grade Glioma|Temozolomide|Phase III|Wait or Treat
Interventions: DRUG: Temozolomide|RADIATION: Radiotherapy|PROCEDURE: Surgery
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer
Status: COMPLETED
Conditions: Kidney Cancer
Interventions: BIOLOGICAL: girentuximab|OTHER: placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients
Status: COMPLETED
Conditions: Mycoses|Mycobacterium Avium-Intracellulare Infection|HIV Infections
Interventions: DRUG: Azithromycin|DRUG: Rifabutin|DRUG: Fluconazole
Study Type: INTERVENTIONAL
Study Design: Allocation: |Intervention Model: |Masking: DOUBLE|Primary Purpose: TREATMENT
Clinical trial: Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis
Status: COMPLETED
Conditions: Lupus Nephritis
Interventions: BIOLOGICAL: Anifrolumab|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Digital vs. Printed Photographs: Impact on Skin Self-Examinations
Status: COMPLETED
Conditions: Melanoma
Interventions: BEHAVIORAL: Digital photographs loaded onto a mobile device|BEHAVIORAL: Skin exam reminders|BEHAVIORAL: Social support network
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Factors Associated With the Use of Lung Protective Ventilation Strategy (LPV) in Acute Lung Injury/Acute Respiratory Distress Syndrome (ALI/ARDS) Patients in Intensive Care Unit (ICU)
Status: COMPLETED
Conditions: Acute Respiratory Distress Syndrome
Interventions: BEHAVIORAL: Quality
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: A Phase Ib/Ⅱ Study of NTQ1062 in Combination With Fulvestrant in Patients With Advanced HR Positive /HER-2 Negative Breast Cancer
Status: RECRUITING
Conditions: HR Positive/HER-2 Negative Breast Cancer
Interventions: DRUG: NTQ1062 with Fulvestrant
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: AI Guidance for Biopsy in Suspected Cholangiocarcinoma
Status: ACTIVE_NOT_RECRUITING
Conditions: Neoplasms|Non-Neoplastic|Bile Duct Neoplasms|Bile Duct Lesions
Interventions: DIAGNOSTIC_TEST: DSOC with AI biopsy guidance|DIAGNOSTIC_TEST: DSOC biopsy without AI guidance
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Low-dose Iron Supplementation in Non-anaemic Iron-deficient Women
Status: NOT_YET_RECRUITING
Conditions: Iron Deficiency (Without Anemia)
Interventions: DIETARY_SUPPLEMENT: Iron|OTHER: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: An Assessment of the Safety and Pharmacokinetics of Ascending Doses of SANGUINATE™ in Healthy Volunteers.
Status: TERMINATED
Conditions: Drug Safety
Interventions: BIOLOGICAL: SANGUINATE™|DRUG: Normal Saline Solution
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Evaluation of Improvements in Patient-reported Quality of Life
Status: RECRUITING
Conditions: Breast Cancer|Quality of Life|Physical Activity|Sleep Quality|Stress|Pain
Interventions: DEVICE: REBECCA system (smartwatch + mobile app use)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Effect of Deep Breathing Exercises on Post Operative Sleep Duration
Status: COMPLETED
Conditions: Coronary Artery Bypass Graft
Interventions: OTHER: Deep Breathing Exercise after every 3hrs, each session consists of 10 deep breaths Exercise|OTHER: Deep Breathing Exercise after every 3hrs, each session consist of 30 deep breaths Exercise
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Intracameral Mydriasis Versus Topical Mydriasis in Cataract Surgery
Status: TERMINATED
Conditions: Cataract|Phacoemulsification|Mydriasis|Pseudoexfoliation Syndrome
Interventions: PROCEDURE: Intracameral injection of mydriatic agent
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Antiepileptic Drugs and Osteoporotic Prevention Trial
Status: COMPLETED
Conditions: Epilepsy|Bone Loss|Osteoporosis|Fractures
Interventions: DRUG: Risedronate|DRUG: Placebo + Calcium and Vitamin D
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Positron Emission Tomography (PET) During Radio-chemotherapy to Treat Otorhinolaryngological Cancer
Status: COMPLETED
Conditions: Malignant Neoplasm of Head and Neck|Locally Advanced Malignant Neoplasm
Interventions: DEVICE: Positron emission tomography|RADIATION: radiochemotherapy
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Crossover Study to Compare PK of Once Daily LCP-Tacro Tablets to Generic Tacrolimus Capsules Twice Daily.
Status: COMPLETED
Conditions: Renal Failure
Interventions: DRUG: LCP-Tacro|DRUG: Tacrolimus -IR
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: 90% Effective Dose of Phenylephrine Infusions Under Intensive and Standard Treatment
Status: NOT_YET_RECRUITING
Conditions: Adverse Effect
Interventions: DRUG: Alpha-Agonist|DRUG: α-adrenergic receptor agonist
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: TREATMENT
Clinical trial: A Comparison of Video Laryngoscopes and the Direct Laryngoscope in Simulated Normal and Difficult Infant Airway.
Status: COMPLETED
Conditions: Airway Complication of Anesthesia
Interventions: DEVICE: normal airway|DEVICE: difficult airway
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Continuous Data Collection and Analysis for Stroke Prevention Using a Wearable Sensor
Status: WITHDRAWN
Conditions: Atrial Fibrillation
Interventions: DEVICE: Amiigo Watch Only|DEVICE: Amiigo Watch + BodyGuardian
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Safety and Tolerability of Multiple Doses of ITI-214 in Healthy Adults and in Adults With Stable Schizophrenia
Status: TERMINATED
Conditions: Schizophrenia
Interventions: DRUG: ITI-214 Dose A|DRUG: ITI-214 Dose B|DRUG: ITI-214 Dose C|DRUG: ITI-214 Dose D (Elderly)|DRUG: Placebo|DRUG: ITI-214 Dose E|DRUG: ITI-214 Dose F|DRUG: ITI-214 Dose G|DRUG: ITI-214 Dose H|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose:
Clinical trial: Balloon Palpation vs Loss of Resistance Syringe for Safe Endotracheal Tube Cuff Pressure; a Randomized Clinical Trial
Status: COMPLETED
Conditions: Tracheal Damage
Interventions: DEVICE: PBP|DEVICE: LOR|DEVICE: Aneroid manometer
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION
Clinical trial: Comparative Study of Hexvix Blue Light Cystoscopy and White Light Cystoscopy in the Detection of Bladder Cancer
Status: COMPLETED
Conditions: Bladder Cancer
Interventions: DRUG: Hexaminolevulinate Hydrochloride|DEVICE: Richard Wolf Photodynamic Diagnostic Equipment (PDD) system
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Status: COMPLETED
Conditions: Major Depressive Disorder
Interventions: DRUG: PNB01 fixed dose combination of pipamperone and citalopram|DRUG: Citalopram|DRUG: Pipamperone
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Postoperative Analgesia With Erector Spinae Plane Block After Pectus Excavatum Repair in Children
Status: UNKNOWN
Conditions: Pectus Excavatum
Interventions: PROCEDURE: Erector spinae plane block
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Cam Decompression Utilizing the Stryker Hip-Check Software Platform
Status: ACTIVE_NOT_RECRUITING
Conditions: Femoroacetabular Impingement
Interventions: DEVICE: Hipcheck Software|OTHER: Conventional Fluoroscopy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Educating Smokers About Lung Cancer Screening Using Tobacco Quitlines
Status: RECRUITING
Conditions: Lung Carcinoma
Interventions: OTHER: Educational Intervention|OTHER: Educational Intervention|OTHER: Questionnaire Administration|OTHER: Survey Administration
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: Effect of Transcranial Direct Current Stimulation (tDCS) on Tobacco Consumption
Status: COMPLETED
Conditions: Tobacco Use Disorder
Interventions: DEVICE: tDCS procedure|DEVICE: Sham procedure
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Monitoring of Sleep and Behavior of Children 3-7 Years Old Receiving Parent-Child Interaction Therapy With the Help of Artificial Intelligence
Status: COMPLETED
Conditions: Disruptive Behavior|Attention-deficit Hyperactivity|Oppositional Defiant Disorder
Interventions: DEVICE: Garmin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: To Assess the Role of Fecal Microbiota Transplant in Acute Liver Failure
Status: WITHDRAWN
Conditions: Acute Liver Failure
Interventions: DRUG: Standard Medical Treatment|OTHER: Fecal Microbiota Transplant|OTHER: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma
Status: COMPLETED
Conditions: Adult Angiosarcoma|Recurrent Adult Soft Tissue Sarcoma|Stage III Adult Soft Tissue Sarcoma|Stage IV Adult Soft Tissue Sarcoma
Interventions: DRUG: regorafenib
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Bioavailability Study of SPARC001(Study 1) in Healthy Adult Volunteers
Status: COMPLETED
Conditions: Healthy
Interventions: DRUG: SPARC001 type I|DRUG: SPARC001 type II|DRUG: Reference001 type I|DRUG: Reference001 type II
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effects of Telbivudine and Tenofovir Disproxil Fumarate on the Kinetics of Hepatitis B Virus DNA in Chronic Hepatitis B (CHB)
Status: COMPLETED
Conditions: Chronic Hepatitis B
Interventions: DRUG: telbivudine|DRUG: tenofovir disproxil fumarate|DRUG: telbivudine plus tenofovir disproxil fumarate
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Comparison Study of Operation and PEIT for Small, Solitary Hepatocellular Carcinoma (HCC)
Status: COMPLETED
Conditions: Hepatocellular Carcinoma
Interventions: PROCEDURE: Operation|PROCEDURE: Percutaneous ethanol injection therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Pharmacokinetic Analysis of High Dose Methotrexate in Pediatric Lymphoblastic Malignancies
Status: COMPLETED
Conditions: Methotrexate Adverse Reaction
Interventions: DRUG: 3g MTX|DRUG: 5g MTX
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose:
Clinical trial: Glutamatergic Amino Acids and Oxytocin Levels in the Plasma of Patients in First Psychotic Episode (FPE)- Before and After Neuroleptic Treatment
Status: UNKNOWN
Conditions: Schizophrenia|Schizophreniform|Schizoaffective Disorder|Brief Psychotic Episode
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Systematic Withdrawal of Neurohumoral Blocker Therapy in Optimally Responding CRT Patients
Status: COMPLETED
Conditions: Heart Failure (HF)
Interventions: DRUG: beta blockers|DRUG: RAAS blockers
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Study to Investigate the Effects of Sisunatovir on QTc Interval in Healthy Adult Participants.
Status: COMPLETED
Conditions: Healthy
Interventions: DRUG: sisunatovir|DRUG: placebo|DRUG: moxifloxacin|DRUG: sisunatovir
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Spironolactone and Dexamethasone in Patients Hospitalized With COVID-19
Status: UNKNOWN
Conditions: Coronavirus Infection|Pneumonia, Viral
Interventions: DRUG: Spironolactone + Dexamethasone|DRUG: Standard-of-care SARS-CoV-2 treatment
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: TERMINATED
Conditions: Keratoconus|Ectasia|Degeneration
Interventions: DRUG: Ciprofloxicine or Vigamox or other.|DRUG: Nonsteroidal (Acular, Voltaren Xibrom, etc)|DRUG: Steroid (FML, Pred Forte, Flarex, etc.)
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: The Effect of Indacaterol on Exercise Endurance in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Status: COMPLETED
Conditions: Chronic Obstructive Pulmonary Disease
Interventions: DRUG: Indacaterol 300 μg|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Outcome and Improvement of Different Treatment in Arteriosclerosis Obliterans
Status: RECRUITING
Conditions: Arteriosclerosis Obliterans
Interventions: PROCEDURE: open bypass group|PROCEDURE: bare metal stent group|PROCEDURE: plain old balloon angioplasty group|PROCEDURE: drug-coated balloon group|PROCEDURE: directional atherectomy group|PROCEDURE: hybrid repair group
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Stromal Vascular Fraction (SVF) Cells for Non-Operative Treatment of Small Rotator Cuff Tears
Status: WITHDRAWN
Conditions: Rotator Cuff Tears
Interventions: DRUG: Tisseel Injectable Product|BIOLOGICAL: Stromal Vascular Fraction Cells
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Video-Debriefing for Improved Competence Among Skilled Birth Attendants in Lira District-Northern Uganda
Status: UNKNOWN
Conditions: Neonatal Encephalopathy|Helping Babies Breathe (HBB) Training
Interventions: BEHAVIORAL: Video-debriefing with standard HBB training compared with standard HBB training only
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: Multiple Dose Safety and Efficacy Study Evaluating CNS 7056 Versus Midazolam in Patients Undergoing Colonoscopy
Status: COMPLETED
Conditions: Sedation
Interventions: DRUG: A. CNS 7056|DRUG: B. CNS 7056|DRUG: C. CNS 7056|DRUG: D. Midazolam
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Restoration of the Radial Length in Compound Wrist Fractures Using Anterior Locking Plates
Status: UNKNOWN
Conditions: Articular Displaced Fractures of the Lower End of the Radius
Interventions: PROCEDURE: fore locked plate|PROCEDURE: external radiocarpal fixer
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Evaluation of Intradermal Hepatitis B Vaccine After IMIQUIMOD's Application, in Cirrhotics Who Did Not Respond to the Usual Vaccine Regimen
Status: NOT_YET_RECRUITING
Conditions: Cirrhosis, Liver|Vaccination Failure|HBV|Vaccine Reaction
Interventions: DRUG: IMIQUIMOD cream|BIOLOGICAL: HEPATITIS B SURFACE ANTIGEN
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: First Line mFOLFOXIRI + PANITUMUMAB vs mFOLFOX + PANITUMUMAB IN RAS AND BRAF WT METASTATIC COLORECTAL CANCER PATIENTS
Status: COMPLETED
Conditions: Metastatic Colorectal Cancer
Interventions: DRUG: Panitumumab|DRUG: Irinotecan|DRUG: Oxaliplatin|DRUG: l-leucovorin|DRUG: 5-fluorouracil
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Trial Evaluating Induction Therapy With Idarubicin and Etoposide Plus Sequential or Concurrent Azacitidine and Maintenance Therapy With Azacitidine
Status: COMPLETED
Conditions: Acute Myeloid Leukemia (AML)
Interventions: DRUG: Cytarabine|DRUG: Idarubicin|DRUG: Etoposide|DRUG: Azacitidine|DRUG: Lenograstim
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The Effect of Lifestyle Intervention for Hypertriglyceridemia on the Pathogenesis of Adverse Pregnancy Outcome
Status: UNKNOWN
Conditions: Hypertriglyceridemia During Pregnancy
Interventions: BEHAVIORAL: Lifestyle including optimal exercise and diet modification.
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Comparison of Application Effects Between Long- and Standard Short- Peripheral Venous Catheters
Status: RECRUITING
Conditions: Hospitalized Patients
Interventions: DEVICE: Long peripheral venous catheter|OTHER: Control group (Short peripheral venous catheter)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: OTHER
Clinical trial: Polysomnographic Titration of Non-invasive Ventilation in Motor Neurone Disease
Status: RECRUITING
Conditions: Motor Neuron Disease / Amyotrophic Lateral Sclerosis
Interventions: OTHER: Intervention polysomnography|OTHER: Sham polysomnography
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Trial Comparing Mini-Arc Precise Pro and the Trans Vaginal Obturator Tape for Stress Urinary Incontinence
Status: UNKNOWN
Conditions: Stress Urinary Incontinence|Urethral Sling Surgery
Interventions: DEVICE: Mini Arc Precise Pro and Trans vaginal obturator sling (TVT-0)
Study Type: INTERVENTIONAL
Study Design: Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT
Clinical trial: BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreaticobiliary Cancer
Status: TERMINATED
Conditions: Metastatic Pancreatic Cancer
Interventions: DRUG: Gemcitabine 1000mg/m2 30 minutes|DRUG: Lapatinib 1000mg/d|DRUG: Lapatinib 1500mg/d|DRUG: Gemcitabine 1000mg/m2 100minutes|DRUG: Oxaliplatin 100mg/m2
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Bioequivalence Study of Losartan Potassium (100 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Cozaar® (100 mg Tablet) [Reference Formulation, Merck & Co. Inc., USA] in Healthy Human Volunteers Under Fasting Condition
Status: COMPLETED
Conditions: Healthy
Interventions: DRUG: Losartan Potassium Tablets
Study Type: INTERVENTIONAL
Study Design: Allocation: |Intervention Model: |Masking: |Primary Purpose:
Clinical trial: Time Effect of the Pressure Release Technique Application in the Latent Myofascial Trigger Points
Status: COMPLETED
Conditions: Myofascial Pain Syndrome
Interventions: OTHER: Pressure release 90|OTHER: Pressure release 60|OTHER: Pressure release 30
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Clinical Trial of Poly-L-lactic Acid (Sculptra Aesthetic) for the Treatment of Cellulite of the Buttocks and Thighs
Status: UNKNOWN
Conditions: Cellulite
Interventions: DEVICE: Sculptra Aesthetic
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: The RELAX Trial: Nonpharmaceutical Intervention for Nocturnal Muscle Cramps
Status: COMPLETED
Conditions: Cramps|Muscle Cramp
Interventions: BEHAVIORAL: Behavioral intervention one|BEHAVIORAL: Behavioral intervention two
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer
Status: TERMINATED
Conditions: Platinum Sensitive Ovarian Cancer|Ovarian Cancer
Interventions: BIOLOGICAL: FRα peptide plus Adjuvant (GM-CSF)|DRUG: Adjuvant (GM-CSF) Alone
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Volar Plating or External Fixation of Dorsally Displaced Fractures of the Distal Radius?
Status: COMPLETED
Conditions: Radius Fractures
Interventions: PROCEDURE: closed reduction and external fixation|PROCEDURE: Internal fixation with a volar locked plate
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza
Status: COMPLETED
Conditions: Influenza
Interventions: DRUG: Nitazoxanide|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Melphalan and Autologous Stem Cell Transplant Followed By Bortezomib and Dexamethasone in Treating Patients With Previously Untreated Systemic Amyloidosis
Status: COMPLETED
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: DRUG: bortezomib|DRUG: dexamethasone
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: N2001-03: CEP-701 in Treating Young Patients With Recurrent or Refractory High-Risk Neuroblastoma
Status: COMPLETED
Conditions: Neuroblastoma
Interventions: DRUG: lestaurtinib
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Safety, Tolerability and Pharmacokinetics After Administration of Increasing Dose of BIBN 4096 BS in Healthy Male and Female Volunteers
Status: COMPLETED
Conditions: Healthy
Interventions: DRUG: BIBN 4096 BS - in single rising doses|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: DOUBLE|Primary Purpose: TREATMENT
Clinical trial: Clinical Trial Ceftriaxone in Subjects With ALS
Status: COMPLETED
Conditions: Amyotrophic Lateral Sclerosis|ALS
Interventions: DRUG: ceftriaxone|OTHER: placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Postpartum Smoking Relapse Prevention by Breastfeeding Promotion
Status: COMPLETED
Conditions: Smoking, Cigarette|Breastfeeding
Interventions: BEHAVIORAL: Breastfeeding promotion|BEHAVIORAL: Attention placebo control
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Sham Feeding Post-operative Infants
Status: COMPLETED
Conditions: Newborn Morbidity|Oral Aversion|Gastroschisis|Bowel Obstruction|Short Bowel Syndrome
Interventions: PROCEDURE: Sham Feeding
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Atropine-effect During Propofol/Remifentanil Induction
Status: COMPLETED
Conditions: Anesthesia-induced Negative Hemodynamic Effects
Interventions: DRUG: Placebo|DRUG: Atropine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: The Use of Oxytocin, Carbetocin and Buccal Misoprostol in Patients Undergoing Elective Cesarean Section (CS)
Status: COMPLETED
Conditions: Postpartum Hemorrhage
Interventions: DRUG: Syntocinon|DRUG: Carbetocin|DRUG: Misoprostol
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: A Study to Evaluate the Effects of 3 Months Dosing With GW856553, as Assessed FDG-PET/CT Imaging
Status: COMPLETED
Conditions: Atherosclerosis
Interventions: DRUG: LOSMAPIMOD 7.5 MG|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: A Prospective Safety Surveillance Study of Fentanyl Iontophoretic Transdermal System (40 Mcg)
Status: TERMINATED
Conditions: Pain
Interventions: DRUG: fentanyl iontophoretic transdermal system (40mcg) No Placebo|DRUG: IV PCA with standard of care opioid analgesia
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Usefulness of Capillary Refill Time and Skin Mottling Score to Predict Intensive Care Unit Admission
Status: UNKNOWN
Conditions: Shock, Septic|Shock, Hemorrhagic
Interventions: OTHER: Capillary refill time and skin mottling score measurement at the admission to the emergency department
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: A Study of Mirikizumab (LY3074828) Injection in Healthy Participants
Status: COMPLETED
Conditions: Healthy
Interventions: BIOLOGICAL: Mirikizumab Test|BIOLOGICAL: Mirikizumab Test|BIOLOGICAL: Mirikizumab Reference
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Non-surgical Periodontal Treatment in Smokers on SIRT-1, NLRP3 Inflammasome and LncRNAs
Status: NOT_YET_RECRUITING
Conditions: Periodontitis, Adult
Interventions: DIAGNOSTIC_TEST: Before non-surgical periodontal treatment|PROCEDURE: non-surgical periodontal treatment|DIAGNOSTIC_TEST: 3rd month after non-surgical periodontal treatment
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Safety and Immunogenicity of V114 in Healthy Adults (V114-019/PNEU-AGE)
Status: COMPLETED
Conditions: Pneumococcal Infections
Interventions: BIOLOGICAL: V114|BIOLOGICAL: Prevnar 13®
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: Safety, Tolerability, Pharmacokinetics and Efficacy of AZD1208 in Acute Myelogenous Leukemia (AML) Patients
Status: TERMINATED
Conditions: Acute Myeloid Leukemia
Interventions: DRUG: AZD1208
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effect of Metformin on Gut Microbiota Changes and Glycemic Control of Newly Diagnosed Type 2 Diabetes
Status: COMPLETED
Conditions: Type 2 Diabetes
Interventions: DRUG: Metformin Hydrochloride
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Ketamine for Postoperative Pain in Bariatric Surgery
Status: UNKNOWN
Conditions: Pain, Postoperative|Bariatric Surgery Candidate
Interventions: DRUG: Ketamine|DRUG: Saline|DRUG: Ketamine|DRUG: Ketamine|DRUG: Ketamine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: SL-401 in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed and Refractory Multiple Myeloma
Status: TERMINATED
Conditions: Multiple Myeloma
Interventions: DRUG: SL-401 7 µg/kg/day|DRUG: SL-401 9 µg/kg/day
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The Effect of a Probiotic Strain on Aspirin-induced GI Damage
Status: TERMINATED
Conditions: Reduction of Small Intestinal Ulceration Risk
Interventions: DIETARY_SUPPLEMENT: Bif195|DIETARY_SUPPLEMENT: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone Therapy
Status: WITHDRAWN
Conditions: Prostate Cancer
Interventions: DRUG: paclitaxel|DRUG: vinorelbine tartrate
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: PNF Techniques to Improve Bed Mobility, Transfer and Early Trunk Control in Stroke Patients
Status: COMPLETED
Conditions: Stroke
Interventions: OTHER: Proprioceptive neuromuscular facilitation|OTHER: Conventional treatment
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Empagliflozin Impact on Hemodynamics in Patients With Heart Failure
Status: COMPLETED
Conditions: Heart Failure
Interventions: DRUG: Empagliflozin 10 mg Tab|DRUG: Placebo Oral Tablet
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: PREDICTive FactOR of Overall Survival Among Geriatric Assessment Tools and Disease Related Factors in Elderly Patients With High Risk Myelodysplastic Syndromes.
Status: COMPLETED
Conditions: Myelodysplastic Syndromes
Interventions: OTHER: research of disease-related factors|OTHER: research of comorbidities|OTHER: physical performance
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER
Clinical trial: A Study of RD14-01 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
Status: RECRUITING
Conditions: Mantle Cell Lymphoma|Diffuse Large B-cell Lymphoma|Follicular Lymphoma
Interventions: DRUG: RD14-01 cell infusion
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Study of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases
Status: ACTIVE_NOT_RECRUITING
Conditions: Hepatocellular Carcinoma|Liver Metastases
Interventions: OTHER: Best Supportive Care|RADIATION: Palliative Radiation Therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus
Status: ENROLLING_BY_INVITATION
Conditions: Systemic Lupus Erythematosus
Interventions: DRUG: Dapirolizumab pegol
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Status: COMPLETED
Conditions: Lung Cancer
Interventions: DRUG: Cisplatin|DRUG: Etoposide|RADIATION: Radiation therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Prosthetic Rehabilitation and Its Influence on Masticatory Performance and QoL in Patients Treated for HNC
Status: ENROLLING_BY_INVITATION
Conditions: Quality of Life|Objective Masticatory Performance|Subjective Masticatory Performance|Oral Health
Interventions: PROCEDURE: Prosthetic oral rehabilitation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: SCREENING
Clinical trial: To Assess the Bioequivalence of Brotizolam Tablets 250 Mcg vs. Lendormin Tablets 250 Mcg Administered to Healthy Adult Volunteers
Status: COMPLETED
Conditions: Healthy
Interventions: DRUG: Lendormin tablet|DRUG: Brotizolam tablet
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM
Status: TERMINATED
Conditions: Peripheral Arterial Disease (PAD)|Diabetes Mellitus (DM)|Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2|Cardiovascular Disease|Critical Limb Ischemia (CLI)
Interventions: DRUG: REX-001|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Efficacy and Safety of Durvalumab in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis
Status: UNKNOWN
Conditions: Leptomeningeal Metastasis|Durvalumab
Interventions: DRUG: Durvalumab|DRUG: methotrexate
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Functional Movement Analysis (FMS) of Diaphragmatic Breathing-Immediate Effect on Shoulder Mobility
Status: COMPLETED
Conditions: Shoulder Pain|Diaphragm Issues
Interventions: OTHER: Shoulder Mobility|PROCEDURE: Diaphragmatic Breathing
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Increasing Implementation of Post-Operative Opioid Prescribing Guidelines
Status: COMPLETED
Conditions: Surgery|Opioid Use|Opioid Misuse|Prescription Opioid Misuse
Interventions: OTHER: Opioid Prescribing Report Cards
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: GTI-2040 and Docetaxel in Treating Patients With Recurrent, Metastatic, or Unresectable Locally Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Other Solid Tumors
Status: COMPLETED
Conditions: Recurrent Non-small Cell Lung Cancer|Recurrent Prostate Cancer|Stage III Prostate Cancer|Stage IIIA Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer|Stage IV Prostate Cancer|Unspecified Adult Solid Tumor, Protocol Specific
Interventions: BIOLOGICAL: GTI-2040|DRUG: docetaxel|OTHER: laboratory biomarker analysis|OTHER: pharmacological study
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis
Status: COMPLETED
Conditions: Plaque Psoriasis
Interventions: DRUG: IDP-118 Lotion|DRUG: IDP-118 Vehicle Lotion
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: LDE225 + Docetaxel/Prednisone for Adv/Met Castrate Resistant Prostate Cancer w/ Disease Progression After Docetaxel
Status: WITHDRAWN
Conditions: Prostate Cancer
Interventions: DRUG: Docetaxel|DRUG: Prednisone|DRUG: LDE225
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: High Dose Methotrexate With Leucovorin Rescue With or Without Glucarpidase in Osteosarcoma
Status: TERMINATED
Conditions: Osteosarcoma
Interventions: DRUG: glucarpidase|DRUG: leucovorin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: TREATMENT
Clinical trial: A Multiple-center Study on the Effect of Different Ways of Lymph Node Dissection on the Prognosis of Ground Glass Nodules Smaller Than 3cm and With More Than 50% Solid Components
Status: RECRUITING
Conditions: Progression
Interventions: PROCEDURE: Lymphadenectomy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: OTHER
Clinical trial: Efficacy and Safety of Hyaluronic Acid Injection on Symptoms of Vulvovaginal Atrophy in Postmenopausal Women
Status: COMPLETED
Conditions: Vulvovaginal Atrophy
Interventions: DEVICE: Injection of DESIRIAL®|OTHER: Injection of placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Role of Endothelin-1 Modulating Insulin-stimulated Blood Flow and Sympathetic Nervous System Activity in Obesity
Status: WITHDRAWN
Conditions: Insulin Resistance|Autonomic Dysfunction|Obesity
Interventions: DRUG: Hyperinsulinemic, euglycemic infusion
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Elastic Compression Stockings for Prevention of Post-thrombotic Syndrome
Status: COMPLETED
Conditions: Deep Vein Thrombosis|Post-thrombotic Syndrome
Interventions: DEVICE: 25mmHg ECS|DEVICE: 35 mmHg ECS
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: A Comparison of the Effect of Dorzolamide and Timolol on Optic Disk Blood Flow in Patients With Open Angle Glaucoma
Status: COMPLETED
Conditions: Glaucoma, Open-Angle
Interventions: DRUG: Dorzolamide 2%|DRUG: Timolol 0.5%
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Assessment of Tube Position According to the Changes of Neck Position Between Two Different Types of Nasotracheal Tubes
Status: NOT_YET_RECRUITING
Conditions: Nasotracheal Intubation
Interventions: DEVICE: Portex|DEVICE: Mallinckrodt
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Efficacy of TACE With Endoscopic Therapy for Unresectable Hepatocellular Carcinoma
Status: COMPLETED
Conditions: Hepatocellular Carcinoma|Esophagogastric Varices
Interventions: PROCEDURE: transarterial chemoembolization combined with endoscopic therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Using the Telephone to Improve Care in Childhood Asthma
Status: COMPLETED
Conditions: Asthma
Interventions: BEHAVIORAL: Telephone Asthma Program
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Dose Escalation Study of Liposomal Paclitaxel With/Without Capecitabine in Patients With Advanced Gastric Carcinoma
Status: UNKNOWN
Conditions: Gastric Carcinoma
Interventions: DRUG: Liposomal paclitaxel and capecitabine
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Qualitative Study on the Perception of Changes in the Psychotherapy of Traumatized Young People
Status: RECRUITING
Conditions: Post-traumatic Stress Disorder
Interventions: BEHAVIORAL: Semi-structured interviews|BEHAVIORAL: Child Post-Traumatic Stress Response Index (CPTS-RI) scale|BEHAVIORAL: - Therapeutic Alliance Questionnaire (HAQ-CP)
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Effect of Propofol on Cardioprotective Role of Remote Ischemic Preconditioning (RIPC)
Status: COMPLETED
Conditions: Myocardial Infarction
Interventions: OTHER: Control|DRUG: Propofol|DRUG: Sevoflurane
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Transition to LIVE (Long-term In Home Ventilation Engagement) Study
Status: RECRUITING
Conditions: Long-term Ventilation at Home
Interventions: DEVICE: aTouchAway™ platform
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment Compared With Tacalcitol Ointment in Patients With Psoriasis on the Face and Skin Folds
Status: COMPLETED
Conditions: Psoriasis Vulgaris
Interventions: DRUG: Calcipotriol plus hydrocortisone ointment vehicle|DRUG: Tacalcitol Ointment|DRUG: Calcipotriol plus hydrocortisone ointment
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: TRANSFORM OCT TRiple Assessment of Neointima Stent FOrmation to Reabsorbable polyMer With Optical Coherence Tomography
Status: UNKNOWN
Conditions: Coronary Artery Lesions
Interventions: DEVICE: EES SYNERGY™|DEVICE: ZES, RESOLUTE Integrity™
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effect of Language and Confusion on Pain During Peripheral Intravenous Catheterization (KTHYPE)
Status: COMPLETED
Conditions: Anaesthesia
Interventions: OTHER: Hypnotic communication|OTHER: negative connotation communication|OTHER: neutral connotation communication|OTHER: peripheral intravenous catheterization
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: OTHER
Clinical trial: Neural Correlates of Stress Reduction
Status: COMPLETED
Conditions: Stress|Psychological Stress|Life Stress|Emotional Stress|Social Stress
Interventions: BEHAVIORAL: Stress Reduction
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Efficacy and Tolerability of Lidocaine Plaster for Treatment of Long-term Local Nerve Pain
Status: COMPLETED
Conditions: Pain|Chronic Pain|Neuropathic Pain|Postoperative Pain
Interventions: DRUG: Lidocaine 5% medicated plaster|DRUG: Placebo plaster
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Specific Neurotechnical Strength Training (NeuroTraining)
Status: COMPLETED
Conditions: Neuromuscular Adaptations
Interventions: OTHER: Speed Loss 20% Strength Training|OTHER: Reduced Rest Time Strength Training
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: OTHER